Side-Chain Chemistry of Charged Residues Reshapes α-synuclein Structure and Aggregation
Researchers found that substituting lysine with arginine in α-synuclein—two positively charged amino acids with different chemical properties—systematically compacts the protein's structure and accelerates its conversion to amyloid fibrils. The study used X-ray scattering and molecular simulations to show that these subtle chemical differences between similarly charged residues significantly alter the protein's conformational ensemble. This finding challenges simplified models of intrinsically disordered proteins and suggests that precise residue identity, not just net charge, is critical for understanding protein misfolding diseases like Parkinson's.
A new study published on bioRxiv demonstrates that the specific chemical identity of charged amino acids plays a more important role in protein structure than previously recognized. Using α-synuclein—a protein implicated in Parkinson's disease—researchers systematically replaced lysine residues with arginine, two positively charged amino acids that differ in side-chain chemistry. Small-angle X-ray scattering (SAXS) experiments revealed that increasing arginine content progressively compacted the protein's conformational ensemble, with effects dependent on both the number and position of substitutions. Molecular-dynamics simulations showed that arginine substitutions stabilize transient long-range contacts, reducing structural heterogeneity. Critically, this arginine-driven compaction correlated with accelerated aggregation into amyloid fibrils—the toxic form associated with neurodegeneration. The findings suggest that current coarse-grained models of intrinsically disordered proteins, which often group amino acids by net charge alone, miss important structural determinants.
What's missing
The study does not discuss potential therapeutic implications of these findings or whether similar side-chain chemistry effects occur in other disease-associated intrinsically disordered proteins beyond α-synuclein.
What different sources said
- bioRxivCenter
Not All Charges Are Equal: Side-Chain Chemistry Reshapes the Disordered Ensemble of α-synuclein
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.